Position in BIOA
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$1,941,091
+$834,748 QoQ
Shares Held
79,196
+25.2% QoQ
Ownership
0.173%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#54
of 151 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 89%
Shared 0%
None 11%
Common Shares in BIOA Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Russell Investments Group, Ltd. holds $362,370,004 across 49 Drug Manufacturers - Specialty & Generic names. BIOA ranks #23 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
893,500 | $64,206,902 | |
| 2 | NBIX |
Neurocrine Biosciences Inc
|
329,065 | $55,460,607 | |
| 3 | VTRS |
Viatris Inc
|
3,423,675 | $54,367,956 | |
| 4 | UTHR |
UNITED THERAPEUTICS Corp
|
61,355 | $33,243,974 | |
| 5 | ELAN |
Elanco Animal Health Inc
|
1,112,894 | $27,388,318 | |
| 6 | LNTH |
Lantheus Holdings, Inc.
|
147,146 | $16,324,370 | |
| 7 | TEVA |
Teva Pharmaceutical Industries Ltd
|
427,444 | $14,481,798 | |
| 8 | ALKS |
Alkermes plc.
|
222,624 | $11,665,496 |
All Filings in BIOA
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,941,091 | 79,196 | Shares | Defined | 2026-08-06 | |
| 2026-03-31 | $1,106,343 | 63,256 | Shares | Other | 2026-05-08 | |
| 2025-12-31 | $546,501 | 41,308 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $26,630 | 4,529 | Shares | Defined | 2025-11-13 | |
| No filing history on record for this holder in this stock. | ||||||